KAI-1678

· KAI Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KAI-1678, covering 2011-09-02 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury [Phase 2]